The Infectious Disease Society of America (IDSA) is asking for more information on the federal government's plan for deciding how and where to supply the only drug so far shown to help patients infected with the novel coronavirus.
- The Infectious Disease Society of America is asking for more information on the federal government’s plan for deciding how and where to supply the only drug so far shown to help patients infected with the novel coronavirus.The U.S. Food and Drug Administration on Friday gave emergency use authorization to Gilead Sciences Inc’s remdesivir for patients with severe COVID-19 - the disease caused by the coronavirus - clearing the way for broader use in more hospitals around the United States.
The IDSA on Wednesday called on the Trump Administration to explain how it will ensure equitable distribution of remdesivir to states and hospitals based on COVID-19 case and hospitalization rates. Gilead last week donated 1.5 million vials of the drug to U.S. hospitals, enough to treat at least 140,000 patients.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Will Gilead price its coronavirus drug for public good or company profit?Gilead Sciences Inc faces a new dilemma in deciding how much it should profit from the only treatment so far proven to help patients infected with the novel coronavirus.
Read more »
Remdesivir emergency supplies to hospitals: Gilead coronavirus drug - Business InsiderHospitals are stuck waiting for supplies of a promising coronavirus treatment to arrive, days after health authorities OK'd its emergency use
Read more »
Japan approves Gilead Sciences' remdesivir as COVID-19 drugJapan has approved Gilead Sciences Inc's remdesivir as a treatment for COVID-19, the health ministry said on Thursday, making it the country's first officially authorized drug for the coronavirus disease.
Read more »
Who can make Gilead's coronavirus drug, licence free?Gilead Sciences Inc is in talks with chemical and drug makers to produce its experimental drug remdesivir, a potential coronavirus treatment, for Europe, Asia and the developing world, the firm has said.
Read more »
Japan approves Gilead Sciences' remdesivir as COVID-19 drugJapan has approved Gilead Sciences Inc's remdesivir as a treatment for COVID-19, the health ministry said on Thursday, making it the country's first officially authorized drug for the coronavirus disease.
Read more »
Column: Newsom is relying on public health officials for his coronavirus response. But he has to listen to others tooIn the U.S. no one rules absolutely — not even public health officials fighting the coronavirus.
Read more »